EI
VNDA icon

Ethic Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

Ethic Inc’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.7K Buy
+11,386
New +$74.4K ﹤0.01% 1341

Other funds holding VNDA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

Ethic Inc's VNDA Position: Q2 2026 in Review

Ethic Inc opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 11,386 shares worth $69.7K. The stake represents ﹤0.01% of the portfolio and ranks #1341 among its holdings.

31 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Ethic Inc held 11,386 shares of Vanda Pharmaceuticals worth $69.7K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Ethic Inc position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1341 holding.
  • 31 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.